Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 1:260:124614.
doi: 10.1016/j.talanta.2023.124614. Epub 2023 May 5.

Bifunctional Au@Pt/Au nanoparticles as electrochemiluminescence signaling probes for SARS-CoV-2 detection

Affiliations

Bifunctional Au@Pt/Au nanoparticles as electrochemiluminescence signaling probes for SARS-CoV-2 detection

Ana M Villa-Manso et al. Talanta. .

Abstract

A novel immunosensor based on electrochemiluminescence resonance energy transfer (ECL-RET) for the sensitive determination of N protein of the SARS-CoV-2 coronavirus is described. For this purpose, bifunctional core@shell nanoparticles composed of a Pt-coated Au core and finally decorated with small Au inlays (Au@Pt/Au NPs) have been synthesized to act as ECL acceptor, using [Ru (bpy)3]2+ as ECL donor. These nanoparticles are efficient signaling probes in the immunosensor developed. The proposed ECL-RET immunosensor has a wide linear response to the concentration of N protein of the SARS-CoV-2 coronavirus with a detection limit of 1.27 pg/mL. Moreover, it has a high stability and shows no response to other proteins related to different virus. The immunosensor has achieved the quantification of N protein of the SARS-CoV-2 coronavirus in saliva samples. Results are consistent with those provided by a commercial colorimetric ELISA kit. Therefore, the developed immunosensor provides a feasible and reliable tool for early and effective detection of the virus to protect the population.

Keywords: COVID-19; Electrochemiluminescence resonance energy transfer; Immunosensor; Metal nanoparticles; N protein; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image 1
Graphical abstract
Scheme 1
Scheme 1
Steps followed for the preparation of the immunosensor (Au@Pt/Au NPs/DAb/Nprotein/CAb-MBs/SPCE) for N protein detection.
Fig. 1
Fig. 1
(A) TEM image of Au NPs. (B) HR-TEM image of Au@Pt/Au NPs with a magnification of a single Au@Pt/Au NP. Au protuberances are labeled with a red circle. (C) AFM topographic image onto HOPG, and topographic profile across the line drawn as an inset. (D) Bright field STEM micrograph of a single nanoparticle, together with Energy dispersive X-ray (EDX) mapping of Au (E) and Pt (F). (G) Normalized UV–vis absorption spectra of 4.500 × 1014 NPs/mL of Au NPs (a), Pt–Au NPs (b) and Au@Pt/Au NPs (c). Normalized ECL emission spectrum (d) of 2.0 mM [Ru (bpy)3]2+ in 0.1 M phosphate buffer, pH 8.0, containing 0.25 mM TPrA obtained under a cyclic potential scan from 0.0 to +1.1 V at 0.03 V/s.
Fig. 2
Fig. 2
(A) EDX analysis and SEM image of Au@Pt/Au NPs/DAb/Nprotein/CAb-MBs/SPCE. (B) ECL responses in presence of 2.0 mM [Ru (bpy)3]2+ in 0.1 M phosphate buffer, pH 8.0, at 0.03 V/s and (C) Nyquist diagrams obtained in 0.1 M phosphate buffer, pH 8.0, with 25 mM KCl in the presence of 1.0 × 10−2 mol/L K3Fe(CN)6/1.0 × 10−2 mol/L K4Fe(CN)6 for a bare SPCE (a), MBs/SPCE (b), CAb-MBs/SPCE (c), Au@Pt/Au NPs/DAb/Nprotein/CAb-MBs/SPCE (d). The N protein concentration was 20 pg/mL.
Fig. 3
Fig. 3
Optimization of different experimental variables: (A) amount of MBs, (B) concentration of Au@Pt–Au NPs, (C) concentration of CAb, (D) incubation time of MBs with CAb, (E) concentration of DAb and (F) incubation time of CAb-MBs with the mixture of N protein and Au@Pt–Au NPs/Dab. Normalized ECL responses (left) measured in the absence (light grey bars) or in the presence (dark grey bars) of 20.0 pg/mL N protein, and the resulting S0/S ratio (right). All the ECL responses were obtained in 0.1 M phosphate buffer, pH 8.0, in presence of 2.0 mM [Ru (bpy)3]2+.
Fig. 4
Fig. 4
(A) Normalized ECL immunosensor response to various concentrations N protein. (B) Calibration curve of normalized ECL intensity vs N protein concentrations (n = 3). (C) Linear plot of the normalized ECL intensity vs logarithmic concentration of N protein (n = 3). (D) Immunosensor response (n = 3) to 20.0 pg/mL N protein obtained in the absence and in presence of 20.0 pg/mL different potential interfering proteins. (E) ECL signal-time curve of 20.0 pg/mL N protein obtained under continuous cycles. (F) Storage stability of the immunosensor measured for 45 days. All measurements were carried out in 0.1 M phosphate buffer, pH 8.0 aqueous solution containing 2.0 mM [Ru (bpy)3]2+.

References

    1. Parihar A., Ranjan P., Sanghi S.K., Srivastava A.K., Khan R. Point-of-Care biosensor-based diagnosis of COVID-19 holds promise to combat current and future pandemics. ACS Appl. Bio Mater. 2020;3:7326–7343. - PubMed
    1. Pinheiro T., Cardoso A.R., Sousa C.E.A., Marques A.C., Tavares A.P.M., Matos A.M., et al. Paper-based biosensors for COVID-19: a review of innovative tools for controlling the pandemic. ACS Omega. 2021;6:29268–29290. - PMC - PubMed
    1. Morales-Narváez E., Dincer C. The impact of biosensing in a pandemic outbreak: COVID-19. Biosens. Bioelectron. 2020;163 - PMC - PubMed
    1. Mollarasouli F., Zare-Shehneh N., Ghaedi M. A review on corona virus disease 2019 (COVID-19): current progress, clinical features and bioanalytical diagnostic methods. Microchim. Acta. 2022;189:103. - PMC - PubMed
    1. Woo C.H., Jang S., Shin G., Jung G.Y., Lee J.W. Sensitive fluorescence detection of SARS-CoV-2 RNA in clinical samples via one-pot isothermal ligation and transcription. Nature Biomedical Engineering. 2020;4:1168–1179. - PMC - PubMed